載入...
Anti-CA15.3 and anti-CA125 antibodies and ovarian cancer risk: Results from the EPIC cohort
BACKGROUND: Neoplastic and non-neoplastic events may raise levels of mucins, CA15.3 and CA125, and generate antibodies against them; but their impact on epithelial ovarian cancer (EOC) risk has not been fully defined. METHODS: CA15.3, CA125, and IgG1 antibodies against them were measured in 806 wome...
Na minha lista:
| 發表在: | Cancer Epidemiol Biomarkers Prev |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
2018
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6309875/ https://ncbi.nlm.nih.gov/pubmed/29661801 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1055-9965.EPI-17-0744 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|